1. Home
  2. WRBY vs MTSR Comparison

WRBY vs MTSR Comparison

Compare WRBY & MTSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WRBY
  • MTSR
  • Stock Information
  • Founded
  • WRBY 2010
  • MTSR 2022
  • Country
  • WRBY United States
  • MTSR United States
  • Employees
  • WRBY N/A
  • MTSR N/A
  • Industry
  • WRBY Ophthalmic Goods
  • MTSR
  • Sector
  • WRBY Health Care
  • MTSR
  • Exchange
  • WRBY Nasdaq
  • MTSR NYSE
  • Market Cap
  • WRBY 2.7B
  • MTSR 3.0B
  • IPO Year
  • WRBY 2021
  • MTSR 2025
  • Fundamental
  • Price
  • WRBY $22.19
  • MTSR $39.47
  • Analyst Decision
  • WRBY Buy
  • MTSR Strong Buy
  • Analyst Count
  • WRBY 16
  • MTSR 6
  • Target Price
  • WRBY $23.33
  • MTSR $55.25
  • AVG Volume (30 Days)
  • WRBY 1.9M
  • MTSR 870.9K
  • Earning Date
  • WRBY 08-07-2025
  • MTSR 08-26-2025
  • Dividend Yield
  • WRBY N/A
  • MTSR N/A
  • EPS Growth
  • WRBY N/A
  • MTSR N/A
  • EPS
  • WRBY N/A
  • MTSR N/A
  • Revenue
  • WRBY $795,094,000.00
  • MTSR N/A
  • Revenue This Year
  • WRBY $16.13
  • MTSR N/A
  • Revenue Next Year
  • WRBY $13.87
  • MTSR N/A
  • P/E Ratio
  • WRBY N/A
  • MTSR N/A
  • Revenue Growth
  • WRBY 13.94
  • MTSR N/A
  • 52 Week Low
  • WRBY $12.46
  • MTSR $12.30
  • 52 Week High
  • WRBY $28.68
  • MTSR $40.47
  • Technical
  • Relative Strength Index (RSI)
  • WRBY 57.54
  • MTSR N/A
  • Support Level
  • WRBY $21.13
  • MTSR N/A
  • Resistance Level
  • WRBY $22.72
  • MTSR N/A
  • Average True Range (ATR)
  • WRBY 0.84
  • MTSR 0.00
  • MACD
  • WRBY -0.09
  • MTSR 0.00
  • Stochastic Oscillator
  • WRBY 71.85
  • MTSR 0.00

About WRBY Warby Parker Inc.

Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

About MTSR METSERA INC

Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions. The Company has developed and is implementing proprietary methods and platform technologies to advance a broad, scalable, and combinable portfolio of injectable and oral NuSH analog peptides with the potential to address not only the limitations of approved therapies but also many of the anticipated limitations of next-generation therapies in development. The Company uses its proprietary MINT peptide library of NuSH analog peptides alongside its Half-life Augmentation by Lipid Optimization half-life extending platform.

Share on Social Networks: